A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms
Park JY, Kim KH
Published in Climacteric
Methodology
Randomized, double-blind, placebo-controlled trial in women aged 40-70 with menopausal symptoms receiving Schisandra chinensis extract (BMO-30) or placebo for six weeks with 12-week follow-up, primary endpoint change in Kupperman Index
Key Findings
Schisandra extract improved Kupperman Index menopausal symptom scores versus placebo in a small completer sample.
Conclusions
Preliminary single-trial support for menopausal symptom relief; not confirmatory.
Limitations
Only 36 completers; single centre; short six-week dosing; proprietary extract.
Supplements Studied
The primary endpoint was the mean interval change in KI score from baseline to week 12.
Study Details
Access Study
Disclosures
Funding
Not reported
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.